Within its last year performance, EPIX fell by -67.53%, with highs and lows ranging from $11.67 to $1.40, whereas the simple moving average fell by -70.14% in the last 200 days.
On November 04, 2024, Piper Sandler Downgraded Essa Pharma Inc (NASDAQ: EPIX) to Neutral. A report published by Oppenheimer on November 04, 2024, Downgraded its rating to ‘Perform’ for EPIX. Oppenheimer Initiated an Outperform rating on June 26, 2023, and assigned a price target of $17. Piper Sandler initiated its ‘Overweight’ rating for EPIX, as published in its report on March 04, 2021. H.C. Wainwright’s report from January 11, 2021 suggests a price prediction of $17 for EPIX shares, giving the stock a ‘Buy’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of Essa Pharma Inc (EPIX)
To gain a thorough understanding of Essa Pharma Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -19.83% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 36.95, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and EPIX is recording an average volume of 842.98K. On a monthly basis, the volatility of the stock is set at 6.15%, whereas on a weekly basis, it is put at 3.55%, with a loss of -2.78% over the past seven days. Furthermore, long-term investors anticipate a median target price of $11.39, showing growth from the present price of $1.75, which can serve as yet another indication of whether EPIX is worth investing in or should be passed over.
How Do You Analyze Essa Pharma Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As opposed to executive stock, institutional ownership accounts for 98.86% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
EPIX shares are owned by institutional investors to the tune of 98.86% at present.
